The identification of TKTL1, which participates in glucose metabolism in cancer cells, sheds a new light on this pathway, as TKTL1 represents an enzyme with transketolase activity and a potentially elevated substrate spectrum with altered reaction characteristics (Coy et al. 2005). This evidence concerns the gene TKT and cancer.